Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions

EuroIntervention. 2008 Aug;4(2):183-6. doi: 10.4244/eijv4i2a33.
No abstract available

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon, Coronary*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Risk Factors
  • Thrombosis / epidemiology
  • Thrombosis / prevention & control*

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors